This empirical evidence, coupled with two landmark studies that highlighted the exquisite hypersensitivity of Ewing sarcoma cell lines to PARP inhibitors57,58, provided the premise for targeted PARP intervention for the treatment of Ewing sarcoma. Here, PARP1 is linked to Ewing sarcoma.